Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Stanford University
Stanford University
Sotio Biotech Inc.
University of Chicago
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Fujian Medical University
Salubris Biotherapeutics Inc
Saint Petersburg State University, Russia
UNICANCER
Kineta Inc.